Home Biotechnology Intas Pharmaceuticals Ltd.
I

Intas Pharmaceuticals Ltd.

Profile managed by Bizz Id
India 500+ employees

Description

Intas is a vertically integrated pharmaceutical company that develops, manufactures and markets formulations, with over 10,000 product registrations worldwide. Its biologics unit develops and manufactures biosimilars —growth factors, hormones and monoclonal antibodies— for India and regulated markets such as the EU, UK and US, where it markets through Accord.

Products

11 products
Denosumab (Jubereq)

Brand: Jubereq (denosumab-desu). Denosumab biosimilar commercially available in the US (Accord BioPharma).

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Denosumab: see suppliers →

Denosumab (Osvyrti)

Brand: Osvyrti (denosumab-desu). Denosumab biosimilar commercially available in the US (Accord BioPharma). REMS program.

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Denosumab: see suppliers →

Filgrastim (Accofil)

Brand: Accofil. Biosimilar marketed in the EU.

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Filgrastim: see suppliers →

Filgrastim (Filkri)

Brand: Filkri (filgrastim-laha). Biosimilar to Neupogen. Launched in the US by Accord BioPharma.

Aprobado FDA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Filgrastim: see suppliers →

Golimumab (Immgolis Intri, infusion)

Brand: Immgolis Intri (golimumab-sldi) for infusion. Accord BioPharma (US).

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Golimumab: see suppliers →

Golimumab (Immgolis)

Brand: Immgolis (golimumab-sldi). Accord BioPharma (US).

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Golimumab: see suppliers →

Pegfilgrastim (Ennumo)

Brand: Ennumo (pegfilgrastim-pccg). Biosimilar to Neulasta. Accord BioPharma's second pegfilgrastim biosimilar (US).

Aprobado FDA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Pegfilgrastim: see suppliers →

Pegfilgrastim (Pelgraz)

Brand: Pelgraz. Pegfilgrastim biosimilar launched across Europe in 2018.

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Pegfilgrastim: see suppliers →

Pegfilgrastim (Udenyca)

Brand: Udenyca (pegfilgrastim-cbqv). Accord BioPharma (US).

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Pegfilgrastim: see suppliers →

Trastuzumab

Brand: Hercessi (trastuzumab-strf). Accord BioPharma (US).

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Trastuzumab: see suppliers →

Ustekinumab

Brand: Imuldosa (ustekinumab-srlf). Accord BioPharma (US).

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Ustekinumab: see suppliers →

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free